METFORMIN and DYSPNOEA

Overview

DYSPNOEA is the #9 most commonly reported adverse reaction for METFORMIN, manufactured by Granules Pharmaceuticals Inc.. There are 13,511 FDA adverse event reports linking METFORMIN to DYSPNOEA. This represents approximately 2.1% of all 631,481 adverse event reports for this drug.

Patients taking METFORMIN who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DYSPNOEA is a less commonly reported adverse event for METFORMIN, but still significant enough to appear in the safety profile.

Other Side Effects of METFORMIN

In addition to dyspnoea, the following adverse reactions have been reported for METFORMIN:

• NAUSEA — 21,943 reports
• DIARRHOEA — 21,886 reports
• BLOOD GLUCOSE INCREASED — 18,325 reports
• DRUG INEFFECTIVE — 18,265 reports
• FATIGUE — 17,247 reports
• ACUTE KIDNEY INJURY — 16,440 reports
• LACTIC ACIDOSIS — 16,153 reports
• VOMITING — 14,691 reports
• OFF LABEL USE — 13,252 reports
• DIZZINESS — 12,130 reports

Other Drugs Associated with DYSPNOEA

The following drugs have also been linked to dyspnoea in FDA adverse event reports:

Does METFORMIN cause DYSPNOEA?

DYSPNOEA has been reported as an adverse event in 13,511 FDA reports for METFORMIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DYSPNOEA with METFORMIN?

DYSPNOEA accounts for approximately 2.1% of all adverse event reports for METFORMIN, making it a notable side effect.

What should I do if I experience DYSPNOEA while taking METFORMIN?

If you experience dyspnoea while taking METFORMIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages